Article
Bleomycin: Synthetic and Mechanistic Studies
15 Feb 1999
Abstract excerpt
The subtleties of the structure and function of bleomycin A2 (1), a clinically employed antitumor agent that derives its biological properties through the sequence-selective cleavage of DNA in a process that is dependent on the metal ion and O2, have been unraveled in a stepwise manner. Systematic modifications in the structure of 1 enabled many of the subtle functional roles of the individual subunits and their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
